465 related articles for article (PubMed ID: 26782006)
1. Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
Yanaba K
J Dermatol; 2016 Jan; 43(1):46-55. PubMed ID: 26782006
[TBL] [Abstract][Full Text] [Related]
2. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
Yoshizaki A
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
[TBL] [Abstract][Full Text] [Related]
3. Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
Zhao M; Wu J; Wu H; Sawalha AH; Lu Q
Clin Rev Allergy Immunol; 2022 Apr; 62(2):273-291. PubMed ID: 33449302
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the diagnosis and treatment of systemic sclerosis.
Kowal-Bielecka O; Bielecki M; Kowal K
Pol Arch Med Wewn; 2013; 123(1-2):51-8. PubMed ID: 23344666
[TBL] [Abstract][Full Text] [Related]
5. New pathogenic and therapeutic concepts in systemic sclerosis.
Hügle T; Huigens CA; van Laar JM
Arzneimittelforschung; 2009; 59(12):615-24. PubMed ID: 20108646
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
Hasegawa M; Fujimoto M; Takehara K; Sato S
J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
[TBL] [Abstract][Full Text] [Related]
7. Disease-modifying treatment in systemic sclerosis: current status.
Quillinan NP; Denton CP
Curr Opin Rheumatol; 2009 Nov; 21(6):636-41. PubMed ID: 19726995
[TBL] [Abstract][Full Text] [Related]
8. B cells in systemic sclerosis: a possible target for therapy.
Bosello S; De Luca G; Tolusso B; Lama G; Angelucci C; Sica G; Ferraccioli G
Autoimmun Rev; 2011 Aug; 10(10):624-30. PubMed ID: 21545850
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
Burt RK; Milanetti F
Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of systemic sclerosis-associated interstitial lung disease].
Prasse A; Bonella F; Müller-Ladner U; Witte T; Hunzelmann N; Distler J
Z Rheumatol; 2020 Apr; 79(3):294-303. PubMed ID: 31754786
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic roles of B lymphocytes in systemic sclerosis.
Yoshizaki A
Immunol Lett; 2018 Mar; 195():76-82. PubMed ID: 29307688
[TBL] [Abstract][Full Text] [Related]
12. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
Hasegawa M; Takehara K
Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
[TBL] [Abstract][Full Text] [Related]
13. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
[TBL] [Abstract][Full Text] [Related]
14. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
Hasegawa M
J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
[TBL] [Abstract][Full Text] [Related]
15. [Updates in systemic sclerosis pathogenesis: Toward new therapeutic opportunities].
Didier K; Robbins A; Antonicelli F; Pham BN; Giusti D; Servettaz A
Rev Med Interne; 2019 Oct; 40(10):654-663. PubMed ID: 31301944
[TBL] [Abstract][Full Text] [Related]
16. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
Del Papa N; Pignataro F; Zaccara E; Maglione W; Minniti A
Front Immunol; 2018; 9():2390. PubMed ID: 30386340
[TBL] [Abstract][Full Text] [Related]
17. Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?
Antic M; Distler JH; Distler O
Curr Opin Pharmacol; 2013 Jun; 13(3):455-62. PubMed ID: 23747024
[TBL] [Abstract][Full Text] [Related]
18. Future treatments in systemic sclerosis.
Asano Y
J Dermatol; 2010 Jan; 37(1):54-70. PubMed ID: 20175840
[TBL] [Abstract][Full Text] [Related]
19. B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
Yoshizaki A
J Dermatol; 2016 Jan; 43(1):39-45. PubMed ID: 26782005
[TBL] [Abstract][Full Text] [Related]
20. Early inflammatory players in cutanous fibrosis.
Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]